Biomarkers for diagnosis, prediction and management

AD. While no test has been identified yet that

fulfils any of these criteria there are some

promising developments from the fields of

molecular biology and genetics and from

neuroimaging (Alzheimer’s Association, NIA,

1998; Geldmacher and Whitehouse, 1997;

Lovestone, 1999).